Evonik, a global leader for functional excipients used in oral solid dosage forms, has launched an advanced combination polymer for enteric coatings.
 
Eudragit FL 30 D-55 leverages Evonik’s new, proprietary AEMP technology (Advanced Excipient Manufacturing Process) to combine the respective benefits of two well-established and monographed polymers including Eudragit L 30 D-55, said a statement from the company.
 
Eudragit FL 30 D-55 is a highly flexible polymer that enables plasticizer-free formulations, making it ideal for the compression of coated multiparticulates.

It can be sprayed with a smooth, fast and no-stick process for excellent adhesion. As a single product, spray suspension preparation times can be reduced by up to 70 per cent, while lowering manufacturing costs and total required polymer volumes. It has also been shown to reduce coating film thicknesses, creating opportunities for increased drug loading.
 
Paul Spencer, global head of oral drug delivery solutions for the Health Care business line of Evonik, said: “As the first ever excipient based upon our proprietary AEMP technology, Eudragit FL 30 D-55 combines the best features of two well-accepted polymers including Eudragit L 30 D-55, which has been the gold standard for enteric coatings for decades.”
 
“This high-tech excipient features extremely high flexibility even without plasticizers. Eudragit FL 30 D-55 sets a new standard for enteric coatings to help customers reduce processing complexity, lower preparation times and save costs,” he said.
 
Hendrik Schoenfelder, president of Evonik Middle East and Africa, said: “With a rapidly growing population in almost all countries across the region of Middle East and Africa, the demand on the healthcare industry increases every day.”

“In some places, like Egypt, government initiatives drive the local production for medicine which boosts the demand for chemical raw materials,” he added. – TradeArabia News Service